Categories Health Care, Interviews

CEO TALKS: The story of Trxade Group (MEDS)

In a casual chat with AlphaStreet, Trxade CEO Suren Ajjarapu speaks about how the medtech company came into existence and the challenges faced in the initial days

Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by the founders themselves while running pharmacies. Suren Ajjarapu and Prashant Patel owned multiple pharmacies in the Tampa Bay area, and first-hand knowledge of the pain points helped them effectively address the business requirement.

Suren, who is currently the CEO of the firm, identifies three major problems that were faced by independent pharmacies – cash flow squeeze caused by reimbursement delays; negative reimbursements due to price discrepancies; as well as lack of adequate data on supply and demand. Trxade was aimed at solving these pain points by bringing multiple suppliers together to ensure better product availability, besides offering pharmacies the required technology bandwidth.  

Initial challenges

According to Suren, convincing clients was an uphill task in the early days. While the company was started in 2010, it took over two years for the firm to acquire its first client.

Obviously, the big suppliers didn’t want us to be there. The pharmacies were used to doing business in certain ways and didn’t want to change this. So it’s a lot of convincing.”

However, things have become easier since. Suren says it’s now possible to demonstrate the savings for these pharmacies through the Trxade platform, making it much easier to talk to clients.  As per the latest earnings release, the company currently has approximately 11,800 registered pharmacies under its network and has established a footprint in all 50 states.

Trxade Group Q3 2020 earnings

Looking ahead

Suren prefers to call Trxade a healthcare IT services company as it provides a business-to-business platform on one end, while offering business-to-customer technology on the consumer side.

We believe that for non-emergency services, the patients should never leave the house. They should be able to talk to the doctor and get the drug delivered wherever they want using our network of pharmacies.”  

Trxade is currently ramping up data analytics facilities to provide more updated and insightful information to clients. The firm is in the process of building algorithms that inform pharmacies key data including supply situation, price fluctuations etc, the CEO said.

Trxade has been serving pharmacies and drug manufacturers for about eight years, leveraging its web-based platform and mobile application. The company’s technology-based services help independent pharmacies compete effectively with larger drug retailers. Its CEO, Suren Ajjarapu, has previously founded multiple firms including Aemetis, Inc and Sansur Renewable Energy, Inc.  

_______

(Written by Arjun Vijay)

For more insights into Trxade Group, read the latest earnings call transcript here.

Most Popular

GameStop (GME) Earnings: Q1 loss narrows on 25% sales growth

Video game retailer GameStop Corp. (NYSE: GME), which has become the talk of the town after the unprecedented stock rally in recent weeks, reported a narrower loss for the first

Should you invest in Steel Dynamics (STLD) stock after 78% rally?

The steel industry managed to shrug off the pandemic blues earlier than expected as the recovery in industrial activity pushed up demand. With the vaccination drive and the government’s aggressive

Campbell Soup (CPB) Q3 Earnings: Key financials and quarterly highlights

Campbell Soup Company (NYSE: CPB) reported third-quarter 2021 earnings results today. Net sales decreased 11% year-over-year to $1.98 billion, as a result of lapping the demand surge at the onset

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top